Key facts
- It has raised $35.9M; the latest was Accelerator/Incubator in Jun 2025.
- Notable investors include Google for Startups, MedTech Innovator, Life Extension Ventures, Arieli Group, bpd partners — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for PMcardio
- ·The full record, as it builds
Funding rounds
No funding rounds for PMcardio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PMcardio
Developer of a healthcare platform designed to support doctors with diagnosis and personalized treatment of cardiovascular diseases. The company's platform offers diagnosis reports, data collection, and personalized treatment plans using the integration of artificial intelligence and machine learning-based algorithms, enabling the medical industry to tackle challenges related to modern medicine and diagnostics.
- Sector
- Healthcare
- HQ
- Bratislava, Slovakia
- Founded
- 2017
- Employees
- 52
- Website
- powerfulmedical.com/
- Ownership
- Privately Held (backing)
PMcardio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PMcardio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PMcardio in its N-PORT filings yet. We sweep new filings monthly.